Biodexa Pharmaceticals
Price & Volume
Stats
See more52W Range | $1.04-$44.40 |
Market Cap | $947,829 |
Shares Short | 20,230 |
Financials
See moreRevenue (12 Mos) | $83,000 |
Revenue Growth (YoY) | -64.1% |
Gross Profit (12 Mos) | -$4.9M |
Diluted EPS | -$26.99 |
News
See moreYahoo Finance • 24 days ago
European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading
Yahoo Finance • 24 days ago
Biodexa Announces Exclusive License of Otsuka’s OPB-171775, a potent Phase 1 ready Molecular Glue for GIST
Yahoo Finance • 2 months ago
European Equities Traded in the US as American Depositary Receipts Start Week Lower in Monday Trading
Yahoo Finance • 2 months ago
European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading
About
CEO | Mr. Stephen Anthony Stamp |
CFO | Ms. Fiona Mary Powell |
Address | 1 Caspian Point, Cardiff, United Kingdom, CF10 4DQ |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 13 |
